PPARA and obesity due to melanocortin 4 receptor deficiency: Many attempts have been made to correct the metabolic disparity that is involved in obesity, using reagents such as sibutramine (an appetite suppressor), orlistat (a gastrointestinal lipid inhibitor), and fibrates (PPAR-α agonists) [68], [69].